SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-050511
Filing Date
2023-06-21
Accepted
2023-06-21 16:17:59
Documents
2
Period of Report
2023-06-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1571
2 POWER OF ATTORNEY ea180676ex24_virpaxpharma.htm EX-24 5499
  Complete submission text file 0001213900-23-050511.txt   8500
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERSARTIS, INC. 1020 MARSH ROAD MENLO PARK CA 94025
Business Address
Shah Vinay (Reporting) CIK: 0001753078 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40064 | Film No.: 231030081